Sonora Investment Management, LLC - BIOMARIN PHARMACEUTICAL INC ownership

Quarter-by-quarter ownership
Sonora Investment Management, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2020$636,000
-88.8%
640,000
-85.1%
0.06%
-89.8%
Q2 2020$5,658,000
+20.6%
4,290,000
-2.2%
0.58%
+4.1%
Q1 2020$4,690,000
-5.7%
4,385,000
-4.7%
0.56%
+18.3%
Q4 2019$4,976,000
+3.9%
4,600,000
-1.5%
0.47%
-5.8%
Q3 2019$4,791,000
-9.2%
4,670,000
-0.7%
0.50%
-15.4%
Q2 2019$5,279,000
-3.2%
4,705,000
-2.2%
0.59%
-11.7%
Q1 2019$5,454,000
-0.3%
4,810,000
-1.5%
0.67%
-15.9%
Q4 2018$5,468,000
-7.4%
4,885,000
-1.3%
0.79%
-2.7%
Q3 2018$5,908,000
+0.4%
4,950,000
-0.8%
0.82%
-10.0%
Q2 2018$5,885,000
-99.9%
4,990,000
-2.4%
0.91%
+0.9%
Q1 2018$5,649,620,000
-8.0%
5,115,000
-0.8%
0.90%
-8.9%
Q4 2017$6,137,595,000
-2.8%
5,155,000
-1.1%
0.99%
-9.9%
Q3 2017$6,312,332,000
+0.3%
5,210,000
-1.4%
1.10%
-7.8%
Q2 2017$6,295,968,000
+0.9%
5,285,000
-0.1%
1.19%
-1.9%
Q1 2017$6,239,343,000
-2.7%
5,290,000
-2.6%
1.21%
-8.5%
Q4 2016$6,411,201,000
-7.4%
5,430,000
-1.8%
1.32%
-8.7%
Q3 2016$6,923,505,000
+7.6%
5,530,000
-1.1%
1.45%
-1.8%
Q2 2016$6,433,196,000
-8.7%
5,590,000
-0.5%
1.48%
-12.9%
Q1 2016$7,047,311,000
+86646.8%
5,620,000
-7.3%
1.70%
-19.8%
Q4 2015$8,124,000
-13.4%
6,060,000
-2.2%
2.12%
-25.4%
Q3 2015$9,377,0006,195,0002.84%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
Birch Grove Capital LP 5,000,000$5,003,0002.71%
Weiss Asset Management LP 65,841,000$64,360,0002.62%
Davide Leone & Partners Investment Co Ltd. 10,500,000$10,513,0001.19%
TENOR CAPITAL MANAGEMENT Co., L.P. 29,597,000$29,800,0001.14%
GLAZER CAPITAL, LLC 7,483,000$7,474,0000.36%
BLUEFIN CAPITAL MANAGEMENT, LLC 52,500$5,243,0000.33%
OAKTREE CAPITAL MANAGEMENT LP 13,428,000$13,444,0000.29%
CSS LLC/IL 5,500,000$5,498,0000.26%
Kohlberg Kravis Roberts & Co. L.P. 40,182,000$40,159,0000.23%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,606,000$2,606,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders